TY - JOUR
T1 - Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17–1A develop a cellular response (DTH) to the “internal image of the antigen” (ab2)
AU - Mellstedt, Håkan
AU - Frodin, Jan‐Erik ‐E
AU - Biberfeld, Peter
AU - Fagerberg, Jan
AU - Gisombe, Ricardo
AU - Hernandez, Aleida
AU - Masucci, Giuseppe
AU - Li, Su‐Ling ‐L
AU - Steinitz, Michael
PY - 1991/5/30
Y1 - 1991/5/30
N2 - The anti‐tumor effector functions of unconjugated MAb in cancer therapy are not fully understood. Direct cytotoxic mechanisms have been demonstrated as well as induction of anti‐idiotypic (ab2) and anti‐anti‐idiotypic (ab3) antibodies. If such a humoral response is induced, then an idiotypic cellular response would also be anticipated. Human monoclonal ab2s which mimic a tumor‐associated antigen (TAA) (CO17–1A) of colorectal carcinoma (CRC) cells (“the internal image of the antigen”) were produced. These ab2s were injected intradermally to patients with metastatic CRC who had been treated with the anti‐colon carcinoma MAb 17–1A (ab1). Five out of 12 patients had a specific DTH (delayed‐type hypersensitivity) reaction of the tuberculin type, which was proven by immunohistochemical analysis of skin biopsies. Serum ab, was demonstrated In 4/4 tested DTH+ patients and also in 4 DTH patients. Control patients did not show any skin reactivity. Generation of an idiotypic response induced by the infused antibody (ab1) might be regarded as an active anti‐tumor “vaccination”. Induction of an idiotypic cellular and humoral cascade might be an important anti‐tumor effector function of MAb and should be considered in future strategies for such therapy in cancer patients.
AB - The anti‐tumor effector functions of unconjugated MAb in cancer therapy are not fully understood. Direct cytotoxic mechanisms have been demonstrated as well as induction of anti‐idiotypic (ab2) and anti‐anti‐idiotypic (ab3) antibodies. If such a humoral response is induced, then an idiotypic cellular response would also be anticipated. Human monoclonal ab2s which mimic a tumor‐associated antigen (TAA) (CO17–1A) of colorectal carcinoma (CRC) cells (“the internal image of the antigen”) were produced. These ab2s were injected intradermally to patients with metastatic CRC who had been treated with the anti‐colon carcinoma MAb 17–1A (ab1). Five out of 12 patients had a specific DTH (delayed‐type hypersensitivity) reaction of the tuberculin type, which was proven by immunohistochemical analysis of skin biopsies. Serum ab, was demonstrated In 4/4 tested DTH+ patients and also in 4 DTH patients. Control patients did not show any skin reactivity. Generation of an idiotypic response induced by the infused antibody (ab1) might be regarded as an active anti‐tumor “vaccination”. Induction of an idiotypic cellular and humoral cascade might be an important anti‐tumor effector function of MAb and should be considered in future strategies for such therapy in cancer patients.
UR - http://www.scopus.com/inward/record.url?scp=0025862966&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910480306
DO - 10.1002/ijc.2910480306
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 2040527
AN - SCOPUS:0025862966
SN - 0020-7136
VL - 48
SP - 344
EP - 349
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 3
ER -